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Carcinomas producing granulocyte colony-stimulating
factor (G-CSF) are known to be extremely malignant
and to carry a poor prognosis [1]. Primary neoplasms
manifesting granulocytosis were first reported in
1951 [2]. Bradley and Metcalf [3] have demonstrated
the biologic effects of G-CSF on granulocytic and
mononuclear cell proliferation.
Renal pelvic carcinoma producing G-CSF is rare,
which is reported in the English literature. We provide
a case of leukemoid reaction from G-CSF producing
urothelial carcinoma (UC) of the renal pelvis.
CASE PRESENTATION
A 75-year-old man presented with left flank pain and
gross hematuria for 3 months. He was admitted to our
hospital and underwent serial examinations. Physical
examination showed a left flank mass with tender-
ness. The leukocyte count was 39,800/μL with 88%
segmented form. There was no evidence of infectious
disease. No abnormal finding in urinary bladder was
noted on cystoscopic examination. The report of urine
cytology was negative. Abdominal computed tomog-
raphy (Figure 1A) showed a mass measuring 12 ×
13 cm in the upper pole of the left kidney with lung
metastasis. Then, angiography (Figure 1B)  showed 
a hypervascular mass, which was supplied by the
anterior division of the left renal artery. Under impres-
sion of renal cell carcinoma due to the hypervascular
pattern seen with angiography, the tumor was selec-
tively embolized by gelfoam pledgets and metallic
coil preoperatively (Figure 1C). The patient underwent
radical nephrectomy and para-aortic lymphadenec-
tomy. The course of treatment was smooth and he
was discharged on the 10th postoperative day.
To our surprise, the diagnosis on the pathologic
report was not renal cell carcinoma as we had sus-
pected preoperatively. It was reported as infiltrating
UC of the renal pelvis (staging: pT4N0M1) with direct
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adrenal gland invasion. Furthermore, the tumor cells
were immunoreactive for G-CSF, vascular endothelial
growth factor (VEGF), and hypoxia-inducible factor 
1 (HIF-1) (Figure 2).
The white blood cell (WBC) count normalized
within 2 weeks postoperatively. Subsequently, systemic
chemotherapy with MVAC was started. Unfortunately,
the WBC count gradually increased without any infec-
tious focus, and he died 10 weeks postoperatively.
DISCUSSION
Malignant neoplasms are often accompanied by
leukocytosis in the absence of any acute infectious
disease or blood disorder [4]. The G-CSF secreted by
tumor cells has been considered to be a cause of
leukocytosis. Several studies have demonstrated 
G-CSF producing tumors, which are characterized 
by leukemoid reaction and mainly involve mature
neutrophils.
Elevated serum G-CSF level was shown to be
associated with poor prognosis in patients with uri-
nary bladder tumor [5].
It was reported that G-CSF produced by transi-
tional cell carcinoma (TCC) of the bladder augments
its autocrine growth [6]. Hematopoietic differentia-
tion of TCC, resulting in acquisition of G-CSF pro-
duction and G-CSF receptor expression, is another
possibility supported by the same study [6].
Renal pelvic carcinoma producing G-CSF is rare.
Higaki et al reported the first case in 2001 [7], followed
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Figure 1. (A) Computed tomography: coronal reconstructional section shows a 12 × 13 cm mass in the upper pole of the left kidney
(star). (B) Angiography shows a hypervascular mass located in the left upper kidney (circle). (C) Selective embolization of the tumor by
the metallic coil is successful (arrow).
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Figure 2. (A) Infiltrating hyperchromatic cancer cells (star) with high N/C ratio in desmoplastic fibrous stroma (hematoxylin & eosin,
100×). (B) Immunohistochemical stain shows that the tumor cells are immunoreactive for G-CSF (arrow).
G-CSF producing UC of the renal pelvis
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by Terao et al [8] in 2005. Although neither of them
received surgical resection, both of them died within
8 weeks of diagnosis.
In this case, the initial diagnosis was renal cell carci-
noma due to its hypervascularity in the angiography
films and negative findings on urine cytology and cys-
toscopy. Therefore, embolization was done routinely
before radical nephrectomy to avoid excess blood loss
intraoperatively.
Although the operation went quite smooth and
leukemoid reaction subsided 2 weeks after operation,
he died 10 weeks postoperatively.
Like the previous two cases [7,8], the tumor cells
were immunoreactive for G-CSF. The result of immuno-
histochemistry study of the tumor cells can make sense
of the interrelationships between leukemoid reaction
and the G-CSF producing tumor cells in our case.
Radical nephrectomy offers a cytoreduction effect and
normalization of the leukocyte count can be obtained
postoperatively even if the tumor has metastasized 
to the lung.
Overexpression of proangiogenic factors by tumor
cells is one mechanism by which tumors can promote
neovascularity. VEGF has also been shown to be
proangiogenic and to promote invasion and metastasis
of human TCC [9]. Transcription of the VEGF gene is
known to be driven by HIF-1, and recent evidence has
suggested that cellular HIF-1 levels are raised not only
by hypoxia but are also increased in the presence 
of reactive oxygen species [10].
Hypervascularity is an uncommon character of
UC of renal pelvis. Interestingly, it was well demon-
strated in the case we presented here. We found that
it may be explained by the ability of the tumor cells
to produce VEGF and HIF-1.
VEGF is a survival factor that protects both tumor
and endothelial cells from exposure to environmental
stresses such as hypoxia or acidosis [11]. Recent reports
indicate that VEGF also protects tumor cells against
chemotherapy-induced apoptosis [12]. It was proved
previously by the relative overexpression of VEGF
observed within residual tumors after MVAC chemo-
therapy [9]. It may reflect the clonal selection resulting
from the death of tumor cells expressing low levels 
of VEGF and the survival of tumor cells expressing
relatively high levels of VEGF, which rendered them
relatively resistant to chemotherapy-induced apop-
tosis [9]. Regarding our case, this may explain the
poor response to chemotherapy since the tumor was
immunoreactive for VEGF. Although the results of
his treatment course were disappointing, radical sur-
gery seems to be the most effective treatment. Enhance-
ment of tumor growth by many cytokines was proved
by our immunohistochemical study. Target therapy to
the specific cytokine is likely to be an alternative
treatment in the future.
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